Accenture, Abivax and 3 Stocks to Watch Heading Into Monday
Stocks in focus: Abivax, Marygold and Neuphoria report losses; Accenture partners with Anthropic, while Lobo Technologies posts H1 growth.
Stocks · News reference
Nasdaq Gains Over 100 Points, Posts Weekly Gain: Investor Sentiment Improves Slightly, But Greed Index Remains in ‘Fear’ Zone
Market sentiment improved slightly but stayed in Fear; stocks were mixed, the Dow had its worst week since March.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Abivax Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Abivax will report H1 earnings Sept. 21; analysts expect a $1.08 loss/share and $1.86M revenue.
This Amer Sports Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Analysts initiate: Buy—Abivax ($155), Amer Sports ($42) and more
Bitcoin Touches $82,000, Ethereum, XRP, Dogecoin Also Gain Amid Tokenization Push by SEC: Analyst Confirms 'Breakout' in This Major Coin
Leading cryptocurrencies rallied on Sunday, September 20, as risk appetite surged following the SEC’s push to introduce tokenized-stock products in the U.S.
Ethereum Treasury Stocks SharpLink and BitMine Eye Further Upside as ETH Targets $3,000 Rebound
Top Ethereum Treasury companies, SharpLink and BitMine are eying a strong rally as ETH price targets the key resistance at $3,000.
Bitcoin Tops $80,000, S&P 500 Slips as Yields Reclaim 5%: Stock Market Today
Crypto-linked equities ripped higher as Bitcoin cleared $80,000, but the S&P 500 slipped with the 10-year Treasury yield back above 5%.